Form 4: Performant Healthcare Director Awarded Future-Vesting Restricted Stock Units

Performant Healthcare Inc. Director William Dean Hansen received an award of 35,616 restricted stock units, granted on July 28, 2025, which will vest in 2026 or upon a change in control.

Summary

• William Dean Hansen, a Director of Performant Healthcare Inc. (PHLT), was awarded 35,616 Restricted Stock Units (RSUs).
• The RSUs were granted on July 28, 2025, at no cost to the reporting person.
• Each RSU represents a contingent right to receive one share of PHLT's common stock.
• The units will vest with respect to 100% of the shares on the earlier of the Registrant's 2026 annual meeting of stockholders or a Change in Control, as defined in the company's Amended and Restated 2012 Stock Incentive Plan.
• The restricted stock units may be settled only for shares of common stock on a one-for-one basis.

Sentiment

Score: 7

Explanation: The filing reports a routine equity compensation award to a director, which is generally viewed positively as it aligns the director's interests with shareholders. There are no negative financial implications or operational concerns raised by this specific filing.

Positives

• The award of Restricted Stock Units to a director aligns management's interests with those of shareholders, as the value of the award is tied to the company's future stock performance.
• Equity compensation is a common method to incentivize long-term commitment and performance from key personnel.

Negatives

• The RSUs have no immediate cash value and are subject to future vesting conditions, meaning the director does not yet beneficially own the underlying shares.
• The vesting is contingent on future events (2026 annual meeting or a Change in Control), introducing a degree of uncertainty regarding the timing of share receipt.

Risks

• The value of the Restricted Stock Units upon vesting is dependent on the future market price of Performant Healthcare Inc.'s common stock, which can fluctuate.
• Vesting is contingent on specific future events (2026 annual meeting or a Change in Control), and if these conditions are not met or delayed, the receipt of shares could be impacted.

Future Outlook

The Restricted Stock Units are set to vest 100% on the earlier of the company's 2026 annual meeting of stockholders or a Change in Control, indicating a future equity distribution tied to corporate events.

Industry Context

The granting of Restricted Stock Units to directors is a standard practice in publicly traded companies across various industries, including healthcare, as a form of non-cash compensation designed to align the interests of directors with long-term shareholder value.

Comparison to Industry Standards

• Equity-based compensation, such as Restricted Stock Units, is a common component of director compensation packages across the healthcare and broader public company landscape.
• The specific size of the award (35,616 units) for a director at Performant Healthcare Inc. would typically be evaluated against peer companies of similar market capitalization and industry sector, though specific comparable data is not provided within this filing.

Corporate Governance

Related Party Transactions

• The award of Restricted Stock Units to Director William Dean Hansen constitutes a transaction between the company and a related party (an insider), which is a standard form of director compensation.

Stakeholder Impact

• Shareholders: The equity award aligns the director's financial interests with shareholder value, potentially encouraging decisions that benefit long-term stock performance.
• Employees: No direct impact on general employees is indicated by this specific filing.

Next Steps

• The Restricted Stock Units are expected to vest on the earlier of Performant Healthcare Inc.'s 2026 annual meeting of stockholders or a Change in Control.

Key Dates

Recommendation

This Form 4 reports a standard equity compensation award to an existing director, which is a routine event and does not provide sufficient new information or material changes to the company's financial or operational outlook to warrant a change in investment recommendation. It primarily serves to disclose insider ownership changes.

Keywords

Performant Healthcare, PHLT, Restricted Stock Units, RSU, Director Compensation, Equity Award, Insider Transaction, Form 4, Corporate Governance